Skip to Main Content

Advertisement

Skip Nav Destination

Issues

IN THIS ISSUE

J Immunol (2019) 202 (12): 3337.

BRIEF REVIEWS

J Immunol (2019) 202 (12): 3339–3348.

ANTIGEN RECOGNITION AND RESPONSES

J Immunol (2019) 202 (12): 3349–3358.

  • The rhesus MHC class I allele, Mamu-B*05104, presents 4-mer lipopeptides to CTLs.

  • Its large, hydrophobic B pocket accommodates the acylated glycine as an anchor.

  • The T cell epitopic diversity appears to be limited for lipopeptides.

J Immunol (2019) 202 (12): 3359–3369.

  • Hp inhibits osteoclastogenesis via the TLR4–IFN-β axis.

  • Hp acts as a ligand for TLR4.

  • Hp promotes IFN-β expression through TLR4.

J Immunol (2019) 202 (12): 3370–3380.

  • We identified an ARF epitope NS1-ARF21–8, encoded by NS1 mRNA of influenza A virus.

  • NS1-ARF21–8 elicits robust immunodominant TCD8+ response in infected BALB/c mice.

  • NS1-ARF21–8 precursor (14-residue peptide) has no detectable biological function.

AUTOIMMUNITY

J Immunol (2019) 202 (12): 3381–3393.

  • Low-dosage p110δ inhibitor therapy prevents PTEN- but not SHP-1–driven autoimmunity.

  • Effective p110δ inhibitor dosages spare immune responses to exogenous immunogens.

  • Low-dosage p110δ inhibitor therapy delays T1D progression in VH125.NOD mice.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2019) 202 (12): 3394–3403.
J Immunol (2019) 202 (12): 3404–3411.

  • MAIT cells require glycolytic metabolism for their cytokine production.

  • MAIT cell glycolysis is regulated by mTORC1 and SLC7A5.

  • MAIT cells display defective glycolytic metabolism in obese adults.

IMMUNE REGULATION

J Immunol (2019) 202 (12): 3412–3422.

  • Loss of glia limitans and infiltration of T cells in the SN is evident in a monkey model of PD.

  • Oral maraviroc protected the endothelial monolayer and reduced T cell infiltration.

  • Oral maraviroc protected the nigrostriatum and improved locomotor activities.

IMMUNE SYSTEM DEVELOPMENT

J Immunol (2019) 202 (12): 3423–3433.

  • Combined deficiency of Ssb1 and Ssb2 abrogates early B cell development.

  • SSB1/2 depletion causes defects in proliferation, genome fragility, and apoptosis.

  • Mature B cells largely tolerate SSB1/2 loss.

J Immunol (2019) 202 (12): 3434–3446.

  • ISWI ATPase Smarca5 guides developmental mRNA program of β-selected thymocytes.

  • Inactivation of Smarca5 gene in developing thymocytes activates p53 and apoptosis.

  • Smarca5 regulates cell fate decisions of γδ thymocytes and survival of pro-B cells.

IMMUNOTHERAPY AND VACCINES

J Immunol (2019) 202 (12): 3447–3457.

  • DCs engineered to overexpress 1,25(OH)2D and RA augment gut-homing Treg cell induction.

  • Transfer of the engineered DCs robustly suppresses ongoing experimental colitis.

  • The engineered DCs require Foxp3+ Treg cells to maximally suppress experimental colitis.

J Immunol (2019) 202 (12): 3458–3467.

  • TILs can be grown from primary bladder tumors.

  • Neoantigen-reactive TILs can be isolated from a bladder tumor specimen.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2019) 202 (12): 3468–3473.

  • GSDMD-deficient mice are more susceptible to melioidosis.

  • In vivo production of IL-1β by neutrophils is independent of GSDMD.

  • GSDMD and pyroptosis are directly microbicidal.

J Immunol (2019) 202 (12): 3474–3482.

  • PGE2 treatment reduces the ability of PMN to kill Listeria monocytogenes.

  • Cells from the livers of infected BALB mice produced more PGE2 than those from C57BL/6 mice.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2019) 202 (12): 3483–3492.

  • Murine SIDT1 colocalizes with late endolysosomes and interacts with long dsRNA [poly(I:C)] but not siRNA or dsDNA.

  • SIDT1 expression is induced following type I IFN and poly(I:C) stimulation.

  • Loss of SIDT1 impairs IFNβ production following infection with HSV-1 but does not affect overall survival.

MOLECULAR AND STRUCTURAL IMMUNOLOGY

J Immunol (2019) 202 (12): 3493–3506.

  • The bat MHC I exhibits distinctive structural characteristics.

  • Significant differences exist in the peptidome between inside the cell and outside the cell.

  • A cluster of uniquely inserted residues may help promote high-affinity peptide binding.

J Immunol (2019) 202 (12): 3507–3513.

  • H2-relaxin–specific T cells are detected in the blood of healthy donors.

  • T cell response to H2-relaxin relies on several CD4 T cell epitopes.

  • An H2-relaxin–specific T cell repertoire might account for its clinical immunogenicity.

TRANSPLANTATION

J Immunol (2019) 202 (12): 3514–3523.

  • IL-3 induces allograft fibrosis and chronic rejection of heart transplants.

  • IL-3 exerts profibrotic effects by activation of infiltrating basophils.

  • IL-6 is an important basophil-derived mediator of fibrosis.

TUMOR IMMUNOLOGY

J Immunol (2019) 202 (12): 3524–3536.

  • A single delivery of R-DOTAP plus peptide Ag induces regression of large tumors.

  • R-DOTAP possesses intrinsic immunostimulatory activity mediated by type I IFN.

  • R-DOTAP activity requires Myd88 but not STING or TRIF, and it activates TLR7 and 9.

Close Modal

or Create an Account

Close Modal
Close Modal